جاهز للتشغيل
جاهز للتشغيل
A new blood test measuring the p-tau217 protein could predict the risk of developing Alzheimer's disease up to 10 years before symptoms appear. Researchers studied nearly 2,700 cognitively healthy adults and found that high levels of the biomarker correlated with a significant likelihood of cognitive decline within a decade. The test offers potential for early diagnosis, risk assessment, and development of preventive treatments.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading